iRhythm Technologies, Inc.

NasdaqGS:IRTC 株式レポート

時価総額:US$3.3b

このページの翻訳は実験的なもので、現在開発中です。お待ちしております!

iRhythm Technologies マネジメント

マネジメント 基準チェック /24

iRhythm Technologies'の CEO はQuentin Blackfordで、 Oct2021年に任命され、 の在任期間は 2.67年です。 の年間総報酬は$ 16.60Mで、 4.1%給与と95.9%のボーナス(会社の株式とオプションを含む)で構成されています。 は、会社の株式の0.23%を直接所有しており、その価値は$ 6.92M 。経営陣と取締役会の平均在任期間はそれぞれ2年と6.9年です。

主要情報

Quentin Blackford

最高経営責任者

US$16.6m

報酬総額

CEO給与比率4.1%
CEO在任期間2.7yrs
CEOの所有権0.2%
経営陣の平均在職期間2yrs
取締役会の平均在任期間6.9yrs

経営陣の近況

Recent updates

iRhythm Technologies (NASDAQ:IRTC) Is Carrying A Fair Bit Of Debt

May 13
iRhythm Technologies (NASDAQ:IRTC) Is Carrying A Fair Bit Of Debt

iRhythm Technologies, Inc.'s (NASDAQ:IRTC) Business Is Trailing The Industry But Its Shares Aren't

Mar 25
iRhythm Technologies, Inc.'s (NASDAQ:IRTC) Business Is Trailing The Industry But Its Shares Aren't

Here's What Analysts Are Forecasting For iRhythm Technologies, Inc. (NASDAQ:IRTC) After Its Annual Results

Feb 25
Here's What Analysts Are Forecasting For iRhythm Technologies, Inc. (NASDAQ:IRTC) After Its Annual Results

iRhythm Technologies (NASDAQ:IRTC) Has Debt But No Earnings; Should You Worry?

Feb 02
iRhythm Technologies (NASDAQ:IRTC) Has Debt But No Earnings; Should You Worry?

iRhythm Technologies, Inc. (NASDAQ:IRTC) Shares Could Be 30% Below Their Intrinsic Value Estimate

Dec 20
iRhythm Technologies, Inc. (NASDAQ:IRTC) Shares Could Be 30% Below Their Intrinsic Value Estimate

iRhythm Technologies, Inc. (NASDAQ:IRTC) Stocks Shoot Up 25% But Its P/S Still Looks Reasonable

Dec 20
iRhythm Technologies, Inc. (NASDAQ:IRTC) Stocks Shoot Up 25% But Its P/S Still Looks Reasonable

Is Now An Opportune Moment To Examine iRhythm Technologies, Inc. (NASDAQ:IRTC)?

Dec 02
Is Now An Opportune Moment To Examine iRhythm Technologies, Inc. (NASDAQ:IRTC)?

Health Check: How Prudently Does iRhythm Technologies (NASDAQ:IRTC) Use Debt?

Sep 20
Health Check: How Prudently Does iRhythm Technologies (NASDAQ:IRTC) Use Debt?

iRhythm Technologies, Inc. (NASDAQ:IRTC) Shares Could Be 25% Below Their Intrinsic Value Estimate

Aug 30
iRhythm Technologies, Inc. (NASDAQ:IRTC) Shares Could Be 25% Below Their Intrinsic Value Estimate

When Should You Buy iRhythm Technologies, Inc. (NASDAQ:IRTC)?

Jul 04
When Should You Buy iRhythm Technologies, Inc. (NASDAQ:IRTC)?

Is iRhythm Technologies (NASDAQ:IRTC) Using Debt In A Risky Way?

Jun 16
Is iRhythm Technologies (NASDAQ:IRTC) Using Debt In A Risky Way?

Estimating The Intrinsic Value Of iRhythm Technologies, Inc. (NASDAQ:IRTC)

May 26
Estimating The Intrinsic Value Of iRhythm Technologies, Inc. (NASDAQ:IRTC)

iRhythm Technologies, Inc.'s (NASDAQ:IRTC) P/S Is On The Mark

May 08
iRhythm Technologies, Inc.'s (NASDAQ:IRTC) P/S Is On The Mark

What Does iRhythm Technologies, Inc.'s (NASDAQ:IRTC) Share Price Indicate?

Mar 27
What Does iRhythm Technologies, Inc.'s (NASDAQ:IRTC) Share Price Indicate?

Is iRhythm Technologies (NASDAQ:IRTC) Using Debt Sensibly?

Feb 25
Is iRhythm Technologies (NASDAQ:IRTC) Using Debt Sensibly?

Health Check: How Prudently Does iRhythm Technologies (NASDAQ:IRTC) Use Debt?

Nov 24
Health Check: How Prudently Does iRhythm Technologies (NASDAQ:IRTC) Use Debt?

iRhythm falls after reaffirming 2022 guidance

Sep 21

iRhythm: Fairly Priced At Current Multiples, No Need To Size Up

Sep 02

Is iRhythm Technologies (NASDAQ:IRTC) Using Debt In A Risky Way?

Aug 18
Is iRhythm Technologies (NASDAQ:IRTC) Using Debt In A Risky Way?

iRhythm Technologies Q2 results beat estimates, co raises FY 2022 revenue guidance

Aug 04

iRhythm Technologies provides FY22 prelims, commercial chief resigns

Jul 19

iRhythm: Reimbursement Overhang Squashed, Bull Thesis Back Intact

Jun 08

Is iRhythm Technologies (NASDAQ:IRTC) A Risky Investment?

Apr 14
Is iRhythm Technologies (NASDAQ:IRTC) A Risky Investment?

CEO報酬分析

iRhythm Technologies の収益と比較して、Quentin Blackford の報酬はどのように変化したか?
日付総報酬給与会社業績
Mar 31 2024n/an/a

-US$130m

Dec 31 2023US$17mUS$677k

-US$123m

Sep 30 2023n/an/a

-US$105m

Jun 30 2023n/an/a

-US$99m

Mar 31 2023n/an/a

-US$105m

Dec 31 2022US$8mUS$650k

-US$116m

Sep 30 2022n/an/a

-US$128m

Jun 30 2022n/an/a

-US$131m

Mar 31 2022n/an/a

-US$124m

Dec 31 2021US$10mUS$163k

-US$101m

報酬と市場: Quentinの 総報酬 ($USD 16.60M ) は、 US市場 ($USD 6.83M ) の同規模の企業の平均を上回っています。

報酬と収益: Quentinの報酬は増加しましたが、会社は利益を上げていません。


CEO(最高経営責任者

Quentin Blackford (45 yo)

2.7yrs

在職期間

US$16,595,149

報酬

Mr. Quentin S. Blackford serves as an Independent Director of Paragon 28, Inc. since August 1, 2022. He serves as President and Chief Executive Officer since October 04, 2021 and serves as Director at iRhy...


リーダーシップ・チーム

名称ポジション在職期間報酬所有権
Quentin Blackford
President2.7yrsUS$16.60m0.23%
$ 7.6m
Brice Bobzien
Chief Financial Officer1.8yrsUS$5.28m0.0085%
$ 279.2k
Minang Turakhia
Chief Medical & Scientific Officer and Executive VP of Product Innovation2.2yrsUS$5.32m0.011%
$ 365.8k
Patrick Murphy
Chief Business & Legal Officer2.5yrsUS$5.33m0.031%
$ 1.0m
Chad Patterson
Chief Commercial Officer1.9yrsUS$5.77m0.017%
$ 561.8k
Mervin Smith
Executive Vice President of Business Operationsless than a yearデータなしデータなし
Marc Rosenbaum
Senior VP of Finance & Chief Accounting Officerless than a yearデータなし0.0029%
$ 95.7k
Daniel Wilson
Executive VP of Corporate Development & Investor Relations5yrsUS$3.54m0.098%
$ 3.2m
Douglas Devine
Executive Advisor1.3yrsUS$2.72m0.055%
$ 1.8m
Sumi Shrishrimal
Executive VP & Chief Risk Officer2.1yrsデータなし0.075%
$ 2.5m
Stephanie Zhadkevich
Director of Investor Relationsno dataデータなしデータなし

2.0yrs

平均在職期間

45yo

平均年齢

経験豊富な経営陣: IRTCの経営陣は 経験豊富 であると考えられます ( 2年の平均在職年数)。


取締役

名称ポジション在職期間報酬所有権
Quentin Blackford
President2.4yrsUS$16.60m0.23%
$ 7.6m
Ralph Snyderman
Independent Director6.9yrsUS$233.12k0.032%
$ 1.1m
Michael Mirro
Medical Director & Member of Scientific Advisory Boardno dataデータなしデータなし
Bruce Bodaken
Independent Director6.9yrsUS$240.25k0.030%
$ 994.7k
Abhijit Talwalkar
Independent Chairman8.1yrsUS$286.74k0.034%
$ 1.1m
R. Mead
Medical Director & Member of Scientific Advisory Boardno dataデータなしデータなし
James Quinn
Member of Scientific Advisory Boardno dataデータなしデータなし
Cathleen Noel Merz
Independent Director6.2yrsUS$230.62k0.019%
$ 608.3k
Mark Rubash
Independent Director8.3yrsUS$248.12k0.034%
$ 1.1m
Mehdi Razavi
Medical Director & Member of Scientific Advisory Boardno dataデータなしデータなし
Karen Ling
Independent Director2.6yrsUS$239.97k0.020%
$ 671.2k
Jay Alexander
Medical Director & Member of Scientific Advisory Boardno dataデータなしデータなし

6.9yrs

平均在職期間

67yo

平均年齢

経験豊富なボード: IRTCの 取締役会経験豊富 であると考えられます ( 6.9年の平均在任期間)。